TOKYO, Jan 26 (Reuters) - Pfizer Inc. and Astellas Pharma Inc. <4503.T> have received marketing approval from Japan's health ministry for the arthritis treatment Celecox in Japan, the companies said ...
Astellas Pharma Inc and Viatris Pharmaceuticals Japan Inc announced that the two companies have agreed to end the joint sales promotion (co-promotion) of the non-steroidal anti-inflammatory and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results